Truist Financial
CCXI

Truist Financial’s ChemoCentryx, Inc. CCXI Stock Holding History

Truist Financial’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-79,076
Closed -$2.88M – 2904
2021
Q4 		$2.88M Sell
79,076
-1,555
-2% -$54.6K ﹤0.01% 1108
2021
Q3 		$1.38M Sell
80,631
-13,974
-15% -$218K ﹤0.01% 1440
2021
Q2 		$1.27M Buy
94,605
+33,778
+56% +$832K ﹤0.01% 1510
2021
Q1 		$3.12M Hold
60,827
– – 0.01% 1029
2020
Q4 		$3.77M Sell
60,827
-194
-0.3% -$11.1K 0.01% 918
2020
Q3 		$3.34M Buy
61,021
+194
+0.3% +$10.4K 0.01% 876
2020
Q2 		$3.5M Hold
60,827
– – 0.01% 816
2020
Q1 		$2.44M Hold
60,827
– – 0.01% 900
2019
Q4 		$2.41M Buy
+60,827
New +$1.07M ﹤0.01% 1046

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Truist Financial's CCXI Position: Q1 2022 in Review

Truist Financial sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 79,076 shares — an estimated $2.88M sold.

Truist Financial first reported a position in CCXI in Q4 2019 and held it in 9 quarters. The position peaked at $3.77M in Q4 2020. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Truist Financial reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 79,076 ChemoCentryx, Inc. shares in Q1 2022, an estimated $2.88M.
  • Truist Financial first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 9 quarters.
  • Truist Financial's ChemoCentryx, Inc. position peaked at $3.77M in Q4 2020.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.